Guillain-Barr  Syndrome (GBS) is a rare acute autoimmune condition that can cause muscle weakness and paralysis. Although most people fully recover from GBS, recovery can be difficult, and hospitalization is often required. Severe cases of GBS can be life-threatening, and some individuals may experience permanent nerve damage after recovery. Additionally, GBS has no known cure, and while most cases start from a bacterial or viral infection, the cause of GBS is not yet fully understood.
 
The U.S. Centers for Disease Control and Prevention (CDC) estimate that around 3,000 to 6,000 people in the United States develop GBS each year. The National Institutes of Health also support necessary research into the cause and treatment of GBS in the hopes of helping provide better treatment options. For these reasons, I will be introducing a resolution to recognize May 2026 as Guillain-Barr  Syndrome Awareness Month in Pennsylvania.
 
Please join me in raising awareness about GBS and its effects on Pennsylvanians by co-sponsoring this important resolution.